Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city

Diagnostic Microbiology and Infectious Disease

Volumn 66, Issue 4, 2010, Pages 445-448

  Bennett, Jason W ^a   Mende, Katrin ^a,b   Herrera, Monica L ^c   Yu, Xin ^a   Lewis II, James S ^d   Wickes, Brian L ^c   Jorgensen, James H ^e   Murray, Clinton K ^a  

^a SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY HEALTH SYSTEM   (United States)

^e University of Texas Health Science Center   (United States)

Author keywords

AmpC beta lactamase; Carbapenem; Enterobacteriaceae; Extended spectrum beta lactamases; KPC 2; Porins; Texas city

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M15; BETA LACTAMASE SHV; BETA LACTAMASE SHV 1; BETA LACTAMASE SHV 2A; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN D; OUTER MEMBRANE PROTEIN F; OUTER MEMBRANE PROTEIN K35; OUTER MEMBRANE PROTEIN K36; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; UNITED STATES; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; TEXAS;

EID: 77649334726     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.11.013     Document Type: Article

References (24)

1. Anderson K.F., Lonsway D.R., Rasheed J.K., Biddle J., Jensen B., McDougal L.K., Carey R.B., Thompson A., Stocker S., Limbago B., and Patel J.B. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45 8 (2007) 2723-2725
2. Bennett J.W., Herrera M.L., Lewis J.S., Wickes B.W., and Jorgensen J.H. KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob. Agents Chemother. 53 (2009) 292-294
3. Biendo M., Canarelli B., Thomas D., Rousseau F., Hamdad F., Adjide C., Laurans G., and Eb F. Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J. Clin. Microbiol. 46 (2008) 1037-1044
4. Black J.A., Moland E.S., and Thomson K.S. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J. Clin. Microbiol. 43 (2005) 3110-3113
5. CDC. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb. Mortal. Wkly Rep. 58 (2009) 256-260
6. Clinical and Laboratory Standards Institute (CLSI) (2008) Performance standards for antimicrobial susceptibility testing: 18th informational supplement (M100-S18), ed. C.a.L.S. Institute. Wayne, PA: CLSI.
7. Clinical and Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing; 19th informational supplement (M100-S19), ed. C.a.L.S. Institute. Wayne, PA: CLSI.
8. Crowley B., Benedi V.J., and Domenech-Sanchez A. Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob. Agents Chemother. 46 (2002) 3679-3682
9. Domenech-Sanchez A., Hernandez-Alles S., Martinez-Martinez L., Benedi V.J., and Alberti S. Identification and characterization of a new porin gene of Klebsiella pneumoniae: its role in beta-lactam antibiotic resistance. J. Bacteriol. 181 (1999) 2726-2732
10. Doumith M., Ellington M.J., Livermore D.M., and Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63 (2009) 659-667
11. Du B., Long Y., Liu H., Chen D., Liu D., Xu Y., and Xie X. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med. 28 (2002) 1718-1723
12. Jacoby G.A., and Munoz-Price L.S. The new beta-lactamases. N. Engl. J. Med. 352 (2005) 380-391
13. Lewis J.S., Herrera M., Wickes B., Patterson J.E., and Jorgensen J.H. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51 (2007) 4015-4021
14. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin. Microbiol. Infect. 14 Suppl 1 (2008) 82-89
15. Martinez-Martinez L., Pascual A., Hernandez-Alles S., Alvarez-Diaz D., Suarez A.I., Tran J., Benedi V.J., and Jacoby G.A. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother. 43 (1999) 1669-1673
16. Oteo J., Delgado-Iribarren A., Vega D., Bautista V., Rodriguez M.C., Velasco M., Saavedra J.M., Perez-Vazquez M., Garcia-Cobos S., Martinez-Martinez L., and Campos J. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents 32 (2008) 534-537
17. Pages J.M., James C.E., and Winterhalter M. The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6 (2008) 893-903
18. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 34 5 Suppl 1 (2006) S20-S28 discussion S64-S73
19. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., Mulazimoglu L., Trenholme G., Klugman K.P., Bonomo R.A., Rice L.B., Wagener M.M., McCormack J.G., and Yu V.L. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin. Infect. Dis. 39 (2004) 31-37
20. Queenan A.M., and Bush K. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20 (2007) 440-458
21. Rasheed J.K., Biddle J.W., Anderson K.F., Washer L., Chenoweth C., Perrin J., Newton D.W., and Patel J.B. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J. Clin. Microbiol. 46 (2008) 2066-2069
22. Szabo D., Silveira F., Hujer A.M., Bonomo R.A., Hujer K.M., Marsh J.W., Bethel C.R., Doi Y., Deeley K., and Paterson D.L. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob. Agents Chemother. 50 (2006) 2833-2835
23. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., and Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
24. Viveiros M., Dupont M., Rodrigues L., Couto I., Davin-Regli A., Martins M., Pages J.M., and Amaral L. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS ONE e365 (2007) 2